The German nation consolidates its status as an elite economy in the CPhI Pharma Index 2019 Research conducted by CPhI Worldwide, the world’s largest pharmaceutical event, ranks Germany as Europe’s preeminent pharma industry. The data was drawn from the CPhI Annual Report and includes opinions from over 350 international pharma companies. CPhI Worldwide, organised by Informa Markets, is held at Messe Frankfurt on 5-7 November. The CPhI Pharma Index is the only annually produced perception ranking of the world’s top-performing countries. It provides vital insights into the world’s leading pharma economies across all attributes and indicates which markets have the greatest business prospects and growth potential. The results see Germany consolidate its status as an elite pharmaceutical market, finishing ahead of its European rivals in API Manufacturing (7.88), competitiveness (6.48), innovation (7.49) finished product manufacturing (8.02), and growth potential (6.92). Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||